Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

LabCorp launches HIV-1 next generation sequencing assay

Laboratory Corporation of America Holdings, or LabCorp, a provider of diagnostic technologies, and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, has launched HIV GenoSure Archive, a laboratory test to help optimize antiretroviral, or ARV, drug regimens in virally suppressed HIV patients.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Lilly announces plans to realign manufacturing operations at Puerto Rico

Eli Lilly and Company has announced plans to conclude production and pursue a sale of one of its three manufacturing plants in Puerto Rico.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Regeneron and Sanofi announce first-patient dosing in Phase III AD study

Regeneron Pharmaceuticals, Inc., a science-based biopharmaceutical company, and Sanofi have announced the first-patient dosing in a Phase III clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis, or AD, that is not adequately controlled with topical AD medications.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

JENOPTIK revises guidance for 2014

JENOPTIK AG, a medical technology company, has revised guidance for 2014 and expects group revenue to be approximately E600 million.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

ACT appoints new SVP of business development and chief commercial officer

Advanced Cell Technology, Inc., or ACT, a biotechnology company, has appointed LeRoux Jooste as senior vice president, or SVP, of business development and chief commercial officer.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

GlaxoSmithKline and Sumitomo announce termination of co-promotion agreement

GlaxoSmithKline K.K., or GSK, and Sumitomo Dainippon Pharma Co., Ltd., a manufacturer of ethical and general use drugs, have reached an agreement to terminate the co-promotion of GlaxoSmithKline K.K's anti-depressant Paxil CR Tablets 12.5mg and Paxil CR Tablets 25mg as of end of December 2014.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Getinge Q3 net profit decreases

Getinge Group, a medical technology company, has reported that net profit attributable to parent company's shareholders for the third quarter ended September 30, 2014 was SEK366 million, or SEK1.54 per share, compared to SEK413 million, or SEK1.73 per share, for the same quarter ended September 30, 2013.

Published By MarketLine
20 Oct 2014
NewsWire
NewsWire

OctreoPharm receives orphan drug status from FDA for tumor diagnostic agent

OctreoPharm Sciences GmbH, a biopharmaceutical company, has received an orphan drug status from the FDA for its new tumor diagnostic agent, SOMscan.

Published By MarketLine
20 Oct 2014
NewsWire
NewsWire

aap Implantate Q3 sales up

aap Implantate AG, a provider of biomedical implants for human muscular and skeletal systems, has reported that sales from continued operations for the third quarter of 2014 were E7.6 million, compared to E6.3 million for the same period of 2013.

Published By MarketLine
20 Oct 2014
NewsWire
NewsWire

Noven files patent infringement lawsuit against Actavis

Noven Pharmaceuticals, Inc. has filed a lawsuit in the US District Court of New Jersey against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Andrx Corp., and Actavis, Inc. for infringement of Noven patents.

Published By MarketLine
20 Oct 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.